Company Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 07:49:42 2025-07-18 am EDT			5-day change	1st Jan Change
3,003.50 ^INR	+0.71%		+2.63%	+0.10%

Jun. 25	Dr. Lal PathLabs Expands Genomics Capabilities with New Sequencing System	MT
Apr. 28	Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,560 From INR3,315, Keeps at Buy	MT

Business description: Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Number of employees: 4,980

Sales by Activity: Dr. Lal PathLabs Limited

Fiscal Period: March	2021	2022	2023	2024	2025
Running Laboratories	15.81B	20.87B	20.17B	22.27B	24.61B

See all business segments

Geographical breakdown of sales: Dr. Lal PathLabs Limited

Fiscal Period: March	2021	2022	2023	2024	2025
India	15.71B	20.73B	19.95B	22.01B	24.43B
Outside India	104M	140M	220M	259M	184M

See all geographic segments

Executive Committee: Dr. Lal PathLabs Limited

Manager	Title	Age	Since
Shankha Banerjee CEO	Chief Executive Officer	-	2024-05-20
Ved Prakash Goel DFI	Director of Finance/CFO	-	2018-08-09
Jai Prakash Meena COO	Chief Operating Officer	-	2022-03-31
Vinay Gujral CMP	Compliance Officer	-	2023-03-31
Munender Soperna CTO	Chief Tech/Sci/R&D Officer	-	2007-08-31

See DR. LAL PATHLABS LIMITED governance

Composition of the Board of Directors: Dr. Lal PathLabs Limited

Director	Title	Age	Since
Arvind Lal CHM	Chairman	75	2020-03-31
Vandana Lal BRD	Director/Board Member	69	1995-02-13
Rahul Sharma BRD	Director/Board Member	64	2005-07-21
Somya Satsangi BRD	Director/Board Member	55	2019-02-07
Archana Lal Erdmann BRD	Director/Board Member	44	2019-05-16
Rohit Bhasin BRD	Director/Board Member	65	2022-11-07
Arun Kumar Sardari Duggal BRD	Director/Board Member	78	2015-08-20
Gurinder Singh Kalra BRD	Director/Board Member	59	2023-07-26
Rajit Mehta BRD	Director/Board Member	-	2023-07-26

Composition of the Board of Directors

Shareholders: Dr. Lal PathLabs Limited

Name	Equities	%	Valuation
Arvind Lal 30.8 %	25,745,443	30.8 %	839 M ₹
Vandana Lal 19.24 %	16,082,327	19.24 %	524 M ₹
Wasatch Advisors LP 4.959 %	4,145,111	4.959 %	135 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt) 3.747 %	3,132,102	3.747 %	102 M ₹
UTI Asset Management Co. Ltd. (Investment Management) 3.103 %	2,593,797	3.103 %	85 M ₹

List of DR. LAL PATHLABS LIMITED shareholders

Company details: Dr. Lal PathLabs Limited

Dr. Lal PathLabs Ltd.

12th Floor, Tower B, SAS Tower Medicity, Sector-38

122001, Gurgaon

+91 12 4301 6500

http://www.lalpathlabs.com

address Dr. Lal PathLabs Limited(LALPATHLAB)

Medical & Diagnostic Laboratories

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
DR. LAL PATHLABS LIMITED	+0.71%	+2.63%	+0.49%	+48.87%	2.91B
NATERA, INC.	-3.12%	-13.42%	+31.06%	+207.91%	18.97B
SONIC HEALTHCARE LIMITED	+0.99%	+1.43%	+3.45%	-16.21%	8.91B
RADNET, INC.	-2.29%	+3.62%	-7.27%	+191.38%	4.31B
SYNLAB AG	-4.42%	-19.84%	-7.48%	-43.25%	3.28B
GENEDX HOLDINGS CORP.	-3.17%	-5.68%	+144.64%	+49.35%	2.22B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	+0.96%	+4.38%	+0.89%	-61.72%	1.91B
DIAN DIAGNOSTICS GROUP CO.,LTD.	+1.28%	+4.75%	+25.16%	-48.26%	1.35B
FLEURY S.A.	+0.08%	+0.08%	-17.93%	-15.26%	1.24B
VIJAYA DIAGNOSTIC CENTRE LIMITED	-1.71%	+0.75%	+34.28%	+223.52%	1.23B
Average	-1.07%	+0.10%	+20.73%	+53.63%	4.63B
Weighted average by Cap.	-1.69%	-4.64%	+20.34%	+103.77%